Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 in Prostate Cancer
NCT02726113Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Oct 2011
- Primary completion
- Mar 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in prostate cancer (PCa) comparing Vitamin D3 with Placebo (2 arms). Primary endpoint: Changes in Serum Levels of Vitamin D [25(OH)D3] at 2 months. Started Oct 2011; status: completed.
02
Drugs
vitamin d
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02726113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02726113.